Covid 19 Vaccine Mrna

2 indexed presentations.

Reference only for licensed healthcare facilities. These listings support NDC-level identification and quote review, and do not imply current stock, manufacturer sponsorship, or direct purchasing status. Review NDC-level listings, compare package configurations, and request a quote review when needed.

Need a Product Not Listed?

Submit a quote review for unlisted NDCs, item codes, or alternate product presentations.

Drug Directory A-Z | Drug names: C | Drug Search | Request a Quote Review

Generic details

Review dosage forms, strengths, package variations, and manufacturer identifiers associated with Covid 19 Vaccine Mrna.

  • Indexed presentation count: 2 indexed presentations.
  • Common dosage forms: Injection.

Common presentations

Compare presentation differences here, then open the table rows below for NDC-level confirmation.

  • Strength variation: 0.0158 mg / .48mL and 0.042 mg / .418mL.
  • Package variation: 10 Vial, Single-Dose and 10 Syringe, Glass.
  • Manufacturer information is shown for product identification only.

Official references

Use official label-search references for this generic family when your team needs supplemental labeling context.

Showing page 1 of 1
Comirnaty - COVID-19 Vaccine, mRNA 0.0158 mg / .48mL Injection 0.48 mL00069-2501-100.0158 mg / .48mLInjection10 Vial, Single-Dose
Comirnaty - COVID-19 Vaccine, mRNA 0.042 mg / .418mL Injection 0.418 mL00069-2528-100.042 mg / .418mLInjection10 Syringe, Glass

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.